(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (Q3)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 43.68%905.74M | 24.55%333.94M | -43.00%630.37M | -64.86%268.11M | -9.87%1.11B | 761.60%762.95M | 1,539.72%480.59M | 1,283.16%1.23B | --88.55M | --29.31M |
Operating income | 43.68%905.74M | 24.55%333.94M | -43.00%630.37M | -64.86%268.11M | -9.87%1.11B | 761.60%762.95M | 1,539.72%480.59M | 1,283.16%1.23B | 88.55M | 29.31M |
Cost of sales | -67.02%-347.86M | -6.29%-108.52M | 28.97%-208.28M | 45.81%-102.1M | -3.04%-293.22M | -442.58%-188.43M | -2,055.04%-112.84M | -1,325.18%-284.57M | ---34.73M | ---5.24M |
Operating expenses | -67.02%-347.86M | -6.29%-108.52M | 28.97%-208.28M | 45.81%-102.1M | -3.04%-293.22M | -442.58%-188.43M | -2,055.04%-112.84M | -1,325.18%-284.57M | -34.73M | -5.24M |
Gross profit | 32.17%557.88M | 35.78%225.41M | -48.06%422.09M | -71.10%166.01M | -13.77%812.6M | 967.45%574.52M | 1,427.64%367.75M | 1,270.96%942.36M | 53.82M | 24.07M |
Selling expenses | -105.07%-429.21M | 18.91%-123.05M | 31.20%-209.3M | 38.08%-151.75M | 45.60%-304.24M | -31.46%-245.07M | -3,648.83%-182.04M | -3,236.01%-559.22M | ---186.43M | ---4.86M |
Administrative expenses | 31.75%-48.99M | 48.44%-21.2M | 17.38%-71.78M | -43.42%-41.11M | 15.56%-86.89M | -140.57%-28.67M | -172.83%-11.02M | -1,006.90%-102.9M | ---11.92M | ---4.04M |
Research and development expenses | 6.90%-105.52M | 19.66%-44.7M | -24.24%-113.35M | -208.37%-55.64M | 37.56%-91.23M | -47.19%-18.04M | -48.26%-8.37M | -470.47%-146.11M | ---12.26M | ---5.64M |
Revaluation surplus | -124.41%-8.98M | -41.18%6.6M | 631.65%36.8M | 472.12%11.23M | 746.80%5.03M | 346.92%1.96M | -1,203.85%-1.02M | 11.03%594K | --439K | ---78K |
-Changes in the fair value of other assets | -124.41%-8.98M | -41.18%6.6M | 631.65%36.8M | 472.12%11.23M | 746.80%5.03M | 346.92%1.96M | -1,203.85%-1.02M | 11.03%594K | --439K | ---78K |
Impairment and provision | -8,310.00%-821K | -179.61%-288K | -92.86%10K | -245.07%-103K | -61.54%140K | -89.68%71K | 66.67%-27K | 314.12%364K | --688K | ---81K |
-Other impairment is provision | -8,310.00%-821K | -179.61%-288K | -92.86%10K | -245.07%-103K | -61.54%140K | -89.68%71K | 66.67%-27K | 314.12%364K | --688K | ---81K |
Special items of operating profit | -60.72%8.69M | 2.78%9.07M | 1,177.82%22.12M | 811.85%8.83M | 111.05%1.73M | -125.87%-1.24M | 19.73%4.12M | -292.56%-15.67M | --4.79M | --3.44M |
Operating profit | -131.14%-26.97M | 182.91%51.85M | -74.32%86.59M | -122.06%-62.54M | 182.30%337.15M | 287.95%283.54M | 1,221.37%169.4M | 367.14%119.43M | -150.86M | 12.82M |
Financing income | 79.63%15.79M | 288.08%8.66M | 329.72%8.79M | 220.09%2.23M | 157.36%2.05M | 1,352.08%697K | 1,654.55%193K | 1,591.49%795K | --48K | --11K |
Financing cost | -31.27%-2.67M | -13.07%-1.17M | -137.06%-2.03M | -265.02%-1.03M | -733.01%-858K | -335.38%-283K | -393.10%-143K | 25.36%-103K | ---65K | ---29K |
Special items of earning before tax | 24.91%-11.12M | 92.20%-948K | 98.00%-14.81M | 96.86%-12.16M | -10,770.12%-739.6M | -11,283.36%-387.26M | 173.13%1.24M | -41.13%-6.8M | ---3.4M | ---1.7M |
Earning before tax | -131.79%-24.97M | 179.44%58.39M | 119.57%78.54M | 28.86%-73.5M | -454.11%-401.27M | 33.03%-103.31M | 1,437.65%170.69M | 448.64%113.32M | -154.28M | 11.1M |
Tax | 61.57%-12.64M | -24.68%-16.67M | -200.77%-32.88M | -240.35%-13.37M | 440.68%32.63M | 600.42%9.53M | -124.36%-3.88M | -830.71%-9.58M | ---1.9M | ---1.73M |
After-tax profit from continuing operations | -182.36%-37.6M | 148.02%41.72M | 112.39%45.66M | 7.37%-86.87M | -455.35%-368.64M | 39.95%-93.79M | 1,679.76%166.82M | 428.61%103.74M | -156.18M | 9.37M |
Earning after tax | -182.36%-37.6M | 148.02%41.72M | 112.39%45.66M | 7.37%-86.87M | -455.35%-368.64M | 39.95%-93.79M | 1,679.76%166.82M | 428.61%103.74M | -156.18M | 9.37M |
Minority profit | 95.05%-229K | 102.10%235K | -228.86%-4.63M | ---11.2M | ---1.41M | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -174.32%-37.37M | 154.82%41.48M | 113.69%50.28M | 19.31%-75.67M | -454.00%-367.23M | 39.95%-93.79M | 1,679.76%166.82M | 428.61%103.74M | -156.18M | 9.37M |
Basic earnings per share | -171.43%-0.05 | 154.55%0.06 | 107.29%0.07 | 98.88%-0.11 | -108.82%-0.96 | 39.96%-9.84 | 428.16%10.88 | -16.39 | ||
Diluted earnings per share | -171.43%-0.05 | 154.55%0.06 | 107.29%0.07 | 98.88%-0.11 | -108.82%-0.96 | 39.96%-9.84 | 428.16%10.88 | -16.39 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data